These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Vasodilator agents in the treatment of heart failure]. Prati PL, Manfrin M. G Ital Cardiol; 1978 Jan; 8(1):1-11. PubMed ID: 415927 [No Abstract] [Full Text] [Related]
8. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure. Mason DT. Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030 [Abstract] [Full Text] [Related]
9. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure. Massie B, Chatterjee K, Werner J, Greenberg B, Hart R, Parmley WW. Am J Cardiol; 1977 Nov; 40(5):794-801. PubMed ID: 411364 [Abstract] [Full Text] [Related]
10. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH. N Engl J Med; 1986 Jun 12; 314(24):1547-52. PubMed ID: 3520315 [Abstract] [Full Text] [Related]
11. Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure. Massie BM, Kramer B, Shen E, Haughom F. Br Heart J; 1981 Apr 12; 45(4):376-84. PubMed ID: 7225252 [Abstract] [Full Text] [Related]
12. Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs. Packer M, Medina N, Yushak M. Am Heart J; 1982 Nov 12; 104(5 Pt 2):1215-23. PubMed ID: 6753552 [Abstract] [Full Text] [Related]
13. Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate. Williams DO, Bommer WJ, Miller RR, Amsterdam EA, Mason DT. Am J Cardiol; 1977 Jan 12; 39(1):84-90. PubMed ID: 318795 [Abstract] [Full Text] [Related]
14. Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise. Chatterjee K, Massie B, Rubin S, Gelberg H, Brundage BH, Ports TA. Am J Med; 1978 Jul 12; 65(1):134-45. PubMed ID: 99031 [Abstract] [Full Text] [Related]
15. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Steimle AE, Stevenson LW, Chelimsky-Fallick C, Fonarow GC, Hamilton MA, Moriguchi JD, Kartashov A, Tillisch JH. Circulation; 1997 Aug 19; 96(4):1165-72. PubMed ID: 9286945 [Abstract] [Full Text] [Related]
16. [Treatment of cardiac failure with vasodilators (author's transl)]. Imhof P. Schweiz Rundsch Med Prax; 1978 May 30; 67(22):219-29. PubMed ID: 418395 [No Abstract] [Full Text] [Related]
17. Role of isosorbide dinitrate in management of chronic congestive heart failure. Parmley WW. Am Heart J; 1985 Jul 30; 110(1 Pt 2):264-8. PubMed ID: 3893081 [Abstract] [Full Text] [Related]
18. Vasodilator therapy in refractory congestive heart failure: a comparative analysis of hemodynamic and noninvasive studies. Haq A, Rakowski H, Baigrie R, McLaughlin P, Burns R, Tihal H, Hilton D, Feiglin D. Am J Cardiol; 1982 Feb 01; 49(2):439-44. PubMed ID: 6800252 [Abstract] [Full Text] [Related]
19. Role of nitrates in congestive heart failure. Cohn JN. Am J Cardiol; 1987 Nov 16; 60(15):39H-43H. PubMed ID: 3120564 [Abstract] [Full Text] [Related]
20. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure. Gray R, Chatterjee K, Vyden JK, Ganz W, Forrester JS, Swan HJ. Am Heart J; 1975 Sep 16; 90(3):346-52. PubMed ID: 1163426 [Abstract] [Full Text] [Related] Page: [Next] [New Search]